Fortis Healthcare’s wholly-owned subsidiary, Escorts Heart Institute, is contesting a Show Cause Notice issued by the Office of the Commissioner, CGST Delhi Audit-1, in the Delhi High Court. The dispute concerns alleged GST irregularities related to MRP charges from IPD patients for medicines and consumables. The potential financial implication is INR 6.66 Crore plus interest and penalty. The writ petition has been filed in December 2025.
CGST Dispute Overview
Escorts Heart Institute and Research Centre Limited, a wholly-owned subsidiary of Fortis Healthcare, has initiated legal action by filing a writ petition before the Delhi High Court.
Dispute Details
The core of the dispute centers around allegations made by the GST Department, which claims that Escorts Heart Institute incorrectly charged MRP, inclusive of GST, from its in-patient department (IPD) patients for medicines and consumables but did not remit the collected GST to the government. The Show Cause Notice has been issued by the Office of the Commissioner, CGST Delhi Audit-1, New Delhi.
Financial Implications
The potential financial ramifications for Escorts Heart Institute, if the challenge is unsuccessful, could amount to INR 6.66 Crore, in addition to applicable interest and penalties. The legal proceedings are now underway as of December 2025.
Source: BSE